| COPD n = 52 | Controls n = 37 | Total n = 89 |
---|---|---|---|
Mean age, years (IQR) | 69.5 (66–75) | 63.6 (56–70) | 66.7 (60.3–74) |
Male sex, n (%) | 27 (52) | 9 (24.3) | 35 (39.3) |
Current smokers, n (%) | 5 (9.6) | 12 (32.4) | 17 (19.1) |
BMI (kg/m2) | 29.3 (9.4) | 28.6 (9.6) | 29.0 (9.4) |
GOLD stage, n (%) | |||
 1 | 7 (13.5) | N/A | N/A |
 2 | 16 (30.7) | N/A | N/A |
 3 | 12 (23.1) | N/A | N/A |
 4 | 16 (30.7) | N/A | N/A |
 N/A | 1 (1.9) | N/A | N/A |
FEV1, liters (SD) | 1.47 (0.77) | 2.60 (0.77) | 1.95 (0.95) |
FEV1, % of predicted (SD) | 58.4 (74.4) | 92.5 (16.4) | 83.1 (47.6) |
FVC, liters (SD) | 2.71 (1.06) | 3.25 (0.90) | 2.94 (1.02) |
FVC, % of predicted (SD) | 77.5 (60.0) | 89.9 (19.2) | 83.1 (48.6) |
FEV1/FVC ratio | 0.49 (0.13) | 0.80 (0.05) | 0.62 (0.19) |
6 MWD, meters (SD) | 340 (134) | 455 (110) | 391 (137) |
SF36 PCS (SD) | 36.3 (10.6) | 50.8 (8.2) | 42.4 (12.0) |
SF36 MCS (SD) | 53.4 (9.1) | 52.6 (11.4) | 53.1 (10.1) |